Highest-materiality recent filing
Monro Q1 sales fall 4.6% to $287.1M; operating income turns positive but adjusted income drops 84%
Sales $287.1M, down 4.6% YoY; comparable store sales down 1.7%.
Monro initiates strategic alternatives review; Q4 sales down 7.2%, operating loss narrows
Board to evaluate asset sales, refinancing, acquisitions, or sale of Company; no definitive timeline.
Monro Q3 sales down 4% to $293.4M; comp store sales up 1.2%, EPS $0.35, adj EPS $0.16
Revenue $293.4M, down 4.0% YoY; comparable store sales up 1.2% (adjusted for days down 0.8%).
Monro signs CEO Peter Fitzsimmons to 3-year contract; appoints to Board
Fitzsimmons now permanent CEO under 3-year contract; prior AlixPartners engagement cost Monro ~$18.5M through Nov 2025.
Monro, Inc. adopts one-year poison pill after Icahn's ~17% stake; trigger at 17.5%
Icahn Enterprises L.P. accumulated ~17% beneficial ownership of Monro common stock, prompting the rights plan.
Monro Q2: sales down 4.1% to $288.9M, comp store sales up 1.1%, EPS $0.18 ($0.21 adj)
Sales decreased 4.1% to $288.9M from $301.4M YoY due to closure of 145 underperforming stores in Q1.
Q1 revenue $301.0M (+2.7% YoY); comparable store sales +5.7% (prior year -9.9%).
Monro Q4 net loss $21.3M; comparable store sales up 2.8% adj; to close 145 stores in Q1 FY2026
Net loss $21.3M ($0.72 diluted loss per share); adjusted diluted loss $0.09 per share.
Monro appoints AlixPartners' Peter Fitzsimmons as CEO; Michael Broderick departs
Board terminated Michael T. Broderick as President/CEO effective March 27, 2025; he receives termination without cause compensation.
Monro amends tire distribution deal with ATD; receives $6.95M earnout payments
ATD pays Monro $3,474,043 on Feb 21, 2025 and another $3,474,043 by June 25, 2025 to satisfy earnout.
Net sales fell 3.7% to $305.8M; comparable store sales down 0.8% (adj. for days) vs down 5.8% in Q2, a sequential improvement.
Monro Q2 fiscal 2025 revenue falls 6.4% to $301.4M; EPS drops to $0.18 from $0.40
Comparable store sales down 5.8% vs -2.3% last year; sequential 410 bps improvement from Q1.
Monro Q1 sales fall 10.3% to $293.2M; comparable store sales down 9.9%
Sales $293.2M vs $327.0M prior year; comp sales -9.9% vs +0.5%.
Sales decreased 10.3% to $293.2M for the quarter ended June 29, 2024, compared to $327.0M a year ago.
Monro Q4 comps down 7.2% adjusted for days; EPS $0.12, declares $0.28 dividend
Q4 sales $310.1M (flat YoY); comparable store sales +0.1% reported but -7.2% adjusted for days.
Monro Q3 FY2024 sales down 5.2% to $317.7M; comps fall 6.1%, EPS $0.38
Revenue $317.7M vs $335.2M YoY; comparable store sales decreased 6.1% (prior year +5.6%).
Monro Q2 sales down 2.3% to $322.1M; diluted EPS $0.40; comps -2.3%
Q2 sales $322.1M, down 2.3% YoY; comparable store sales -2.3%
Monro shareholders approve board declassification and Class C preferred stock conversion amendments
Board declassification amendment filed Aug 17, 2023; directors will stand for one-year terms starting 2024 meeting, fully declassified by 2025.
Monro Q1 FY2024 sales down 6.5% to $327M; comp store sales +0.5%; adj. EPS $0.31
Diluted EPS $0.28; adjusted diluted EPS $0.31.
Monro Q4 sales $310.8M, GAAP EPS $0.01, adjusted $0.08; comp sales +4.5%
Q4 sales $310.8M, down 5.2% due to wholesale divestiture; comparable store sales +4.5%.
Monro agrees to eliminate Class C Preferred Stock; board declassification plan
Conversion rate adjusted to 61.275 common shares per preferred share (from 23.389), eliminating Class C stock over ~3-year sunset.
Monro Q3 sales -1.9% to $335.2M, comp +5.6%; EPS $0.41; acquires 5 stores
Comparable store sales +5.6% (4.4% adj. for day shift), driven by ~12% increase in ~300 small/underperforming stores.
Monro Q2 sales $329.8M (-5.1% YoY), comps +1.3%, diluted EPS $0.40, adjusted EPS $0.43
Sales decreased 5.1% to $329.8M vs $347.7M prior year; decline due to divestiture of wholesale tire assets.
Monro shareholders withhold majority from two directors; board to explore recapitalization
Directors Donald Glickman and Lindsay N. Hyde did not receive majority votes; they will continue until 2023 annual meeting.
In connection with his departure from Monro, Inc. (the “Company”), on March 31, 2025, Michael T. Broderick resigned from the Company’s board of directors.
On March 27, 2025, the Board terminated Michael T. Broderick from his positions as President and Chief Executive Officer of the Company effective immediately.
On March 28, 2025, the Board of Directors (“Board”) of Monro, Inc. (the “Company”) appointed Peter Fitzsimmons to serve as the President and Chief Executive Officer of the Company effective immediately.
On February 5, 2025, the Board of Directors (“Board”) of Monro, Inc. (the “Company”) appointed Nick Hawryschuk to serve as the Senior Vice President – Operations (“SVP - Operations”) of the Company effective as of February 5, 2025.
On February 27, 2024, Matt Henson, the Chief Human Resources Officer of Monro, Inc. (the “Company”) and the Company agreed that he would leave his position, effective as of March 30, 2024, the end of the Company’s fiscal year (“fiscal 2024”).
On February 15, 2024, the Board of Directors (“Board”) of Monro, Inc. (the “Company”) increased the size of its Board from eight to nine and appointed Thomas B. Okray to the Board.
On February 3, 2023, Frederick M. Danziger retired from the Board of Directors of Monro, Inc. (the “Company”).
Also on February 9, 2023, the Board of Directors (“Board”) appointed Hope B. Woodhouse to fill the vacancy on the Board.
the Company announced the elimination of the role of Chief Operating Officer. As a result of this position elimination, Robert J. Rajkowski will leave the Company as of July 31, 2022.
the Company announced the elimination of the role of Chief Operating Officer. As a result of this position elimination, Robert J. Rajkowski will leave the Company as of July 31, 2022.
appointed Matt Henson to serve as the Chief Human Resource Officer of the Company effective as of July 6, 2021.
Max materiality 0.85 · Median 0.55 · Most common event earnings